NCT00610935

Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza

A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza.

• Status: Terminated
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 82 (actual)
• Sponsor: BioCryst Pharmaceuticals · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine the safety and effectivess of a single intramuscular injection of peramivir for the treatment of subjects with acute, uncomplicated influenza.

Conditions

• Influenza

Interventions

Type	Name	Description
DRUG	Peramivir	To evaluate the efficacy of peramivir administered intramuscularly compared to placebo on the time to alleviation of clinical symptoms in adult subjects with uncomplicated acute influenza.
DRUG	Placebo	Single intramuscular injection

Timeline

• Start date: 2008-01-01
• Primary completion: 2008-02-01
• Completion: 2008-02-01
• First posted: 2008-02-08
• Last updated: 2021-03-17
• Results posted: 2021-03-17

Locations

96 sites across 1 country: United States